SK bioscience announced that, together with IDT Biologika (IDT) and Australian biotechnology company Vaxxas, it has been ...
As shelf-stable microarray patch (MAP) platforms move through development and clinical work, a ‘packaging first’ mentality is needed for industry-wide adoption.
The statistical interaction between genetic susceptibility and lifestyle was significant in the larger cohort and showed similar directional trends in the Indian cohort, according to the study ...
Bionano Genomics, Inc. (Nasdaq: BNGO) today announced highlights from Day 3 of Bionano Symposium 2026, entitled OGM Making its Mark in Constitutional Genetic Disorders. Presentations highlighted how ...
The panel ensures compatibility with our previous autosomal Family Finder tests plus all the autosomal transfers we ...
BioVenic is dedicated to advancing the advancement of veterinary molecular diagnostics through its comprehensive ...
Explore essential statistical strategies for accurate protein quantification and differential expression analysis.
SK bioscience, IDT Biologika, and Vaxxas will collaborate on a next-generation influenza vaccine development initiative.
Thank you. Earlier today, Seer released financial results for the quarter and year ended December 31, 2025. If you've not received this news release or if you'd like to be added to the company's ...
Persistence Market Research, a leading management consulting firm, has released this update on the dental burs market. Dental burs are precision rotary instruments used in a wide range of dental ...
SK Bioscience said Thursday it has secured its first European Union-backed vaccine development project alongside German subsidiary IDT Biologika, marking a key ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results